On March 5, 2018 Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, reported that James Caruso, president and chief executive officer of Cellectar Biosciences, will present a company overview at the following upcoming March 2018 conferences (Filing, 8-K, Cellectar Biosciences, MAR 5, 2018, View Source [SID1234524387]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

30th Annual ROTH Conference

· Date and Time: Tuesday, March 13 at 2:30 pm PT
· Venue: The Ritz Carlton, Orange County, CA
· Webcast: View Source

28th Annual Oppenheimer Healthcare Conference

· Date and Time: Tuesday, March 20 at 4:30 pm ET
· Venue: The Westin New York Grand Central Hotel, New York, NY
· Webcast: https://www.veracast.com/webcasts/opco/healthcare2018/11117262769.cfm

A live and archived webcast of Mr. Caruso’s presentations will be available in the Events and Presentations section of the Company’s website at View Source